For more information, visit:
For more information, visit:
We have some important new information from the HVTN 505 vaccine study to share with you.
We are going to stop further injections in the HVTN 505 study because the vaccine did not show efficacy. This means it did not work to prevent HIV infection nor reduce the amount of virus (viral load) in the blood among people in the study who became infected with HIV. Participants enrolled in the study will be unblinded (find out whether they received a vaccine or placebo) in the upcoming few weeks, but study visits will continue.
The first order of business when we heard this news was to notify our study participants (prior to the release of the information to the public). At this time, all RVA HVTN 505 volunteers enrolled in Rochester and Buffalo have been contacted/informed of this important study update.
Although the news is not what we were hoping for, the ongoing support of our volunteers and our community will continue to allow us to better understand how to develop effective HIV vaccines. This news is extremely disappointing to our team, but the information we gain from this study is critical in planning the future direction of HIV vaccine research and we could not have learned this without your support.
Undoubtedly, there will be a lot of news about this study in the upcoming days and weeks. We are committed to providing accurate information to our volunteers and community partners at the earliest possible time. At this time we can provide you the press release sent out today by the National Institute of Health.
As additional information is released we will share this with you. If you have questions or comments about this study or HIV prevention in general, please don’t hesitate to contact us!
Thank you once again for your commitment to ending AIDS!
The entire Rochester Victory Alliance team
Original article accessed 4/11/13, Microbicide Trials Network: http://www.mtnstopshiv.org/node/4877
Truvada found not an effective strategy in this population
Young, single women were least likely to use tablets or gel, and more likely to get infected at very high rates
By: Amy Young
Updated: March 4, 2013
Today kicked off the National Week of Prayer for the Healing of AIDS. 1.2 million people are living with HIV in the United States. One-fifth of them don’t even know it.
Rochester has the second rate of HIV in New York State, outside of New York City.
In Monroe County more than two-thousand people are diagnosed with HIV. A Rochester congregation is hoping to reach those afflicted and those who may not yet realize they are living with the disease.
I’m proud that the church is finally stepping up and coming out of the fog of not wanting to deal with this very very sensitive issue of HIV and AIDS," said Weldon Thomas, Pastor New Bethel C.M.E. Church.
On this Sunday, Pastor Weldon Thomas’s message hopes to reach those dealing with HIV and AIDS.
"We are realizing that our congregations are being affected more and more. The person sitting in the pew next to your may have a family member, we may have a family members who we’ve had to funeralize. People who are now living with HIV and AIDS and so. Pastors are becoming more sensitive to the fact that we must be at the forefront," added Thomas.
New Bethel C.M.E. Church provided free HIV and AIDS screening before and after this morning’s service.
The pastor also shared the pulpit with Dr. Michael Keefer, a professor at the University of Rochester, conducting clinical research A Professor at the University of Rochester conducting clinical research on preventative vaccines that may one day be the answer to the epidemic.
"The relatively, I think, sad part is that we’ve known for a number of years that the African American and Latino communities are bearing a disproportionate burden of the illness. What’s also distressing is also hitting young people, said Dr. Michael Keefer, University of Rochester.
Jackie Dozier with Minority Health Initiatives was also on hand to help guide those seeking help.
"If we can touch the lives of just one person, then we’ve done some service," said Jackie Dozier, Minority Health Initiatives.
As the title suggests the National Week of Prayer for the Healing of AIDS has various programs and services throughout the coming week, not here in Rochester but throughout the country.
To view the source article and a video of the event, visit: http://rochesterhomepage.net/fulltext?nxd_id=375092
National and local experts, researchers, health-care workers, and activists will discuss the crisis at a symposium, "HIV/AIDS Crisis Among African Americans" from 9 a.m. to 3 p.m. on Friday, October 19. The event is sponsored by the University of Rochester.
One in 16 African-American men and one in 32 African-American women will learn at some point in their lives that they have HIV, according to the Centers for Disease Control and Prevention. Even though African Americans make up less than 14 percent of the US population, they represent half of all new HIV infections, the CDC says.
While scientists inch closer to a vaccine and other breakthroughs, some health-care experts question whether eradicating the disease is even possible until the underlying causes of the crisis are better understood.
Inequities born out of a mix of racism, homophobia, and poverty are helping the disease spread disproportionately in minority communities, says Cathy Bunce, a symposium panel member and principal HIV investigator with the University of Rochester Medical Center. Rochester residents between the ages of 18 to 26 accounted for most of the new cases in the city in 2010, she says.
The symposium is from 9 a.m. to 3 p.m. in the Rush Rhees Library. It’s free and open to the public.
Researchers Look to Western NY for Help in the Search for a Vaccine
February 21, 2011
The Rochester Victory Alliance, the University of Rochester Medical Center’s HIV vaccine clinical trials unit, has opened a satellite clinic in downtown Buffalo to make it easier for volunteers in western New York to participate in ongoing HIV vaccine trials. The office is located at 206 S. Elmwood Ave.
The new location is part of a collaboration with AIDS Community Services of Western NY (ACS), a not-for-profit community-based organization that provides HIV/AIDS education, support and medical services to eight counties in western New York.
“We are excited about bringing HIV preventive services to the Buffalo community and feel fortunate to have found such a great partner as AIDS Clinical Services in Buffalo,” said Rochester Victory Alliance Director Michael Keefer, M.D. “Since the beginning of the AIDS pandemic, ACS has been dedicated to helping people at risk. They share our goal of one day achieving a world without AIDS. While that is still a long way off, they realize that what we all do today can make an important contribution.”
As new HIV/AIDS cases continue to grow each year, the demand for a vaccine is critical. Local and state statistics show that Buffalo and Rochester share similar rates of new HIV infections, with 67 to 69 percent found in men. Over 50 percent of new cases are in people ages 30 to 49, and almost 40 percent are African American. The Centers for Disease Control reports that one in five men who have sex with men are HIV positive and nearly half do not know it. Young men – especially young black men – are least likely to be aware they are infected. Globally, approximately 33 million people live with AIDS today and more than 16 million children have been orphaned due to losing parents to the disease.
The University of Rochester Medical Center was one of the first sites in the nation to conduct HIV vaccine research studies, beginning in 1988. Since then, nearly 1,300 people from the Rochester area have participated in more than 50 vaccine research trials. The Rochester Victory Alliance is a member of the international HIV Vaccine Trials Network, which is supported by the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health. The Rochester Victory Alliance currently works with HIV vaccine research teams in Sao Paulo, Brazil, and South Africa.
For more information about services or volunteering in a trial*, contact the Rochester Victory Alliance at (855) 816-5500, or in Rochester at the University of Rochester Medical Center, 601 Elmwood Ave, Rochester, 14642, (585) 756-2329 (756-2DAY). Visit the Rochester Victory Alliance on Facebook at http://www.RochesterVictoryAlliance.org/and Twitter at http://twitter.com/RocVictAlliance.
*The Rochester Victory Alliance is currently recruiting for a study involving men who have sex with men, the fastest-rising group of new reported HIV/AIDS cases in the U.S. Men interested in volunteering for the study must be between the ages of 18 and 50, healthy, circumcised, sexually active and HIV-negative. Participation requires 10 to 12 confidential office visits, four of which must be at the Victory Alliance in Rochester. Participants will be paid an average of $1,000. The vaccine used in the study is synthetic and cannot cause HIV or AIDS.
For Media Inquiries:
Email Carole Dowling